Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02323165 · ClinicalTrials.gov registry record
A New Method for Detection of Bacteria in the Bloodstream
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 14
- Enrollment target
NCT02323165 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 14 participants.
The verdict
NCT02323165 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The primary aim is to determine if this new technique will detect and identify bacteria in the blood sooner than standard blood cultures or identify patients who may be septic without growing bacteria in their cultures. These will be correlated with the data collected from medical records on presumed sepsis. These results will be linked to data concerning infection that will be available as part of routine care including blood counts and other laboratory values that would be part of the routine medical care such as a white blood cell count. The earlier the bacteria are identified and the appropriate antimicrobials are administered the better the patient outcome.
Interventions
- OTHER Molecular Detection of Bacteria in the Bloodstream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-01 |
| Est. Completion | 2022-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02323165
The ClinicalTrials.gov registry entry for NCT02323165 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Molecular Detection of Bacteria in the Bloodstream is the first listed.
NCT02323165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02323165 about?
NCT02323165 is a clinical study titled "A New Method for Detection of Bacteria in the Bloodstream". The primary aim is to determine if this new technique will detect and identify bacteria in the blood sooner than standard blood cultures or identify patients who may be septic without growing bacteria in their cultures. These will be correlated with the data collected from medical records on presume...
What is the current status of trial NCT02323165?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2015-01. Estimated completion is 2022-03-04.
What interventions are being tested in trial NCT02323165?
The interventions under investigation include: Molecular Detection of Bacteria in the Bloodstream (OTHER).
Who is sponsoring clinical trial NCT02323165?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.